A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
Where should businesses draw the line with large language model utilization?
Advertising big wigs say they may flee Meta platforms if their brands appear next to toxic content. But where else would they go?
Some 8,000 industry movers and shakers are expected today for the annual JPMorgan Healthcare Conference, or simply JPM.